Use of Salt-Water Solution to Improve Symptoms in Concussion
This study has been completed.
Sponsor:
Rady Children's Hospital, San Diego
Information provided by:
Rady Children's Hospital, San Diego
ClinicalTrials.gov Identifier:
NCT00142090
First received: September 1, 2005
Last updated: February 2, 2009
Last verified: January 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to find out if 3% hypertonic saline (salt-water solution) given in a vein improves the headache that may be caused by a concussion. 3% hypertonic saline may also improve some of the other symptoms that may be caused by concussion (for example: confusion, nausea, vomiting).
This research is being done because there have been previous experience which suggests that 3% hypertonic saline has been beneficial in the treatment of children with more severe brain injury.
| Condition | Intervention |
|---|---|
|
Brain Concussion Post-Concussion Symptoms |
Drug: 3% Hypertonic saline Drug: Placebo |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Use of 3% Hypertonic Saline to Improve Clinical Symptoms in Concussed Patients |
Resource links provided by NLM:
MedlinePlus related topics:
Concussion
Dietary Sodium
Drinking Water
Headache
Nausea and Vomiting
Traumatic Brain Injury
U.S. FDA Resources
Further study details as provided by Rady Children's Hospital, San Diego:
Primary Outcome Measures:
- Improvement in headache.
Secondary Outcome Measures:
- Improvement in other clinical symptoms of concussion (decrease level of GCS, nausea, vomiting, inability to recall events, repetitive questioning, and disorientation to person, place, and time).
| Enrollment: | 8 |
| Study Start Date: | November 2004 |
| Study Completion Date: | July 2007 |
| Primary Completion Date: | December 2005 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 2
3% Hypertonic saline
|
Drug: 3% Hypertonic saline |
|
Placebo Comparator: 1
Normal saline
|
Drug: Placebo
Normal saline
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 6 Years to 17 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Greater than or equal to 6 years of age
- Admitted for observation of closed head injury
- GCS greater than or equal to 13
- Presence of headache
- CT scan showing no brain injury or only a small contusion (an area of low attenuation less than 10 mm or a punctuate area of high attenuation with surrounding edema less than 5mm). CT evidence of high or mixed attenuation would be consistent with a hemorrhagic lesion and therefore not qualify to participate in the study. Evidence of skull fractures and cephalohematomas on CT would not exclude the patient from the study.
Exclusion Criteria:
- Age less than 6
- GCS less than 13
- Radiographic evidence of extra-axial blood or subarachnoid blood
- Possible or witnessed posttraumatic seizure
- Developmental delay/ mental retardation
- Underlying cardiac or renal pathology
- Suspected and/or documented use of alcohol and/or illicit substances
- Medication history which includes administration of acetaminophen within 4 hours prior to enrollment or chronic anticoagulant use (ie: Coumadin, Aspirin
- Associated injuries requiring the use of narcotics for analgesia (ie: long bone injuries, deep laceration repair)
- Intubation
- Non-English speaking
- No parental consent
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00142090
Locations
| United States, California | |
| Children's Hospital San Diego | |
| San Diego, California, United States, 92123 | |
Sponsors and Collaborators
Rady Children's Hospital, San Diego
Investigators
| Principal Investigator: | Karim T Rafaat, MD | Rady Children's Hospital, San Diego |
| Study Director: | Bradley M Peterson, MD | Rady Children's Hospital, San Diego |
More Information
No publications provided
| Responsible Party: | Division of Pediatric Critical Care, Rady Children's Hospital, San Diego |
| ClinicalTrials.gov Identifier: | NCT00142090 History of Changes |
| Other Study ID Numbers: | 04139-C, 11266 |
| Study First Received: | September 1, 2005 |
| Last Updated: | February 2, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Rady Children's Hospital, San Diego:
|
Brain Concussion Post-Concussion Syndrome Closed Head Injury Traumatic Brain Injury Hypertonic Saline Solution |
Additional relevant MeSH terms:
|
Brain Concussion Post-Concussion Syndrome Brain Injuries Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Craniocerebral Trauma Trauma, Nervous System Head Injuries, Closed Wounds and Injuries Wounds, Nonpenetrating |
ClinicalTrials.gov processed this record on June 17, 2013